Clinical Trials Browser

Phase 2 × Endometrial Adenocarcinoma × AZD 6244 × Clear all

NCT01011933 2019-07-23

Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer

Phase 2 Completed

54 enrolled 13 charts

Endometrial Adenocarcinoma